Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
A Case of Oesophageal Leishmaniasis Indicating Visceral Leishmaniasis in a Patient with AIDS
Authors
S. Sollima
M. Pizzuto
S. Bonetto
L. Ravasio
A. Tosoni
L. Vago
M. Corbellino
S. Antinori
Publication date
01-11-1999
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/1999
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960050394

Other articles of this Issue 10/1999

European Journal of Clinical Microbiology & Infectious Diseases 10/1999 Go to the issue

Review

Vancomycin Resistance: Status Quo and Quo Vadis

Brief Reports

Evaluation of Modern Agglutination Tests for Identification of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus

Article

Diagnostic Relevance of the Detection of Legionella DNA in Urine Samples by the Polymerase Chain Reaction

Note

Post-Traumatic Course Complicated by Cutaneous Infection with Absidia corymbifera

Article

Incidence of Lyme Borreliosis in the Würzburg Region of Germany

Note

Semiquantitative Polymerase Chain Reaction Enzyme Immunoassay for the Diagnosis of Pertussis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits